PHAT Q2 2021 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PHATPhathom Pharmaceuticals, Inc.

$831M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$131,000

Operating Income

-$35M

Net Income

-$37M

EPS (Diluted)

$-1.00

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$28M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$215M

Total Liabilities

$82M

Stockholders' Equity

$132M

Cash & Equivalents

$210M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$131,000	$0	—
Operating Income	-$35M	-$20M	-76.4%
Net Income	-$37M	-$21M	-73.2%